T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients

Flora Reverchon(Université d'Orléans), Séverine Morisset‐Lopez(Centre National de la Recherche Scientifique)
Biomedicines
September 27, 2022
Cited by 8


Related Papers